10 results
S-3
EX-1.2
CADL
Candel Therapeutics Inc
5 Aug 22
Shelf registration
5:08pm
-corruption law; or (iv) made, offered, authorized, requested, or taken an act in furtherance of any unlawful bribe, rebate, payoff, influence payment
10-K
2021 FY
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
and willfully soliciting, offering, paying, receiving or providing any remuneration (including any kickback, bribe, or certain rebate), directly
424B4
CADL
Candel Therapeutics Inc
28 Jul 21
Prospectus supplement with pricing info
4:02pm
or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind
S-1/A
y7bk8uvedq
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
pbnhlr
16 Jul 21
IPO registration (amended)
6:07am
S-1
v735mlgzco kgmpb21
25 Jun 21
IPO registration
5:28pm
DRS/A
f7or70oiwfcfdaorq
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next